BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 21945767)

  • 1. [Prostaglandin E2 promotes hepatocellular carcinoma cell proliferation through EP2 prostanoid receptor].
    Guo D; Chen NN; Hou LB; Lei LS
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Sep; 31(9):1564-7. PubMed ID: 21945767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin E2 promotes wound-induced migration of intestinal subepithelial myofibroblasts via EP2, EP3, and EP4 prostanoid receptor activation.
    Iwanaga K; Okada M; Murata T; Hori M; Ozaki H
    J Pharmacol Exp Ther; 2012 Mar; 340(3):604-11. PubMed ID: 22138372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
    Meja KK; Barnes PJ; Giembycz MA
    Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E series of prostaglandin receptor 2-mediated activation of extracellular signal-regulated kinase/activator protein-1 signaling is required for the mitogenic action of prostaglandin E2 in esophageal squamous-cell carcinoma.
    Yu L; Wu WK; Li ZJ; Wong HP; Tai EK; Li HT; Wu YC; Cho CH
    J Pharmacol Exp Ther; 2008 Oct; 327(1):258-67. PubMed ID: 18583546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo intra-luteal implants of prostaglandin (PG) E1 or E2 (PGE1, PGE2) prevent luteolysis in cows. II: mRNA for PGF2α, EP1, EP2, EP3 (A-D), EP3A, EP3B, EP3C, EP3D, and EP4 prostanoid receptors in luteal tissue.
    Weems YS; Bridges PJ; Jeoung M; Arreguin-Arevalo JA; Nett TM; Vann RC; Ford SP; Lewis AW; Neuendorff DA; Welsh TH; Randel RD; Weems CW
    Prostaglandins Other Lipid Mediat; 2012 Jan; 97(1-2):60-5. PubMed ID: 22120546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of the prostaglandin E receptor EP2 in paeoniflorin-induced human hepatoma cell apoptosis.
    Hu S; Sun W; Wei W; Wang D; Jin J; Wu J; Chen J; Wu H; Wang Q
    Anticancer Drugs; 2013 Feb; 24(2):140-9. PubMed ID: 23069790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin (PG) FP and EP1 receptors mediate PGF2alpha and PGE2 regulation of interleukin-1beta expression in Leydig cell progenitors.
    Walch L; Clavarino E; Morris PL
    Endocrinology; 2003 Apr; 144(4):1284-91. PubMed ID: 12639911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the EP receptor subtype that mediates the inhibitory effects of prostaglandin E2 on IgE-dependent secretion from human lung mast cells.
    Kay LJ; Gilbert M; Pullen N; Skerratt S; Farrington J; Seward EP; Peachell PT
    Clin Exp Allergy; 2013 Jul; 43(7):741-51. PubMed ID: 23786281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipopolysaccharide stimulates the production of prostaglandin E2 and the receptor Ep4 in osteoblasts.
    Shoji M; Tanabe N; Mitsui N; Tanaka H; Suzuki N; Takeichi O; Sugaya A; Maeno M
    Life Sci; 2006 Mar; 78(17):2012-8. PubMed ID: 16289620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E prostanoid 2 (EP2)/EP4-mediated suppression of antigen-specific human T-cell responses by prostaglandin E2.
    Okano M; Sugata Y; Fujiwara T; Matsumoto R; Nishibori M; Shimizu K; Maeda M; Kimura Y; Kariya S; Hattori H; Yokoyama M; Kino K; Nishizaki K
    Immunology; 2006 Jul; 118(3):343-52. PubMed ID: 16827895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diclofenac suppresses hepatoma cell proliferation and promotes cyclooxygenase-2 mRNA expression].
    Chen NN; Wu SG
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):814-7. PubMed ID: 16793607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin E2 upregulates survivin expression via the EP1 receptor in hepatocellular carcinoma cells.
    Bai XM; Jiang H; Ding JX; Peng T; Ma J; Wang YH; Zhang L; Zhang H; Leng J
    Life Sci; 2010 Jan; 86(5-6):214-23. PubMed ID: 20035770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin E2 suppresses poly I: C-stimulated cytokine production via EP2 and EP3 in immortalized human corneal epithelial cells.
    Ueta M; Matsuoka T; Sotozono C; Kinoshita S
    Cornea; 2012 Nov; 31(11):1294-8. PubMed ID: 22475642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E2-induced modification of tetrodotoxin-resistant Na+ currents involves activation of both EP2 and EP4 receptors in neonatal rat nodose ganglion neurones.
    Matsumoto S; Ikeda M; Yoshida S; Tanimoto T; Takeda M; Nasu M
    Br J Pharmacol; 2005 Jun; 145(4):503-13. PubMed ID: 15821755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of EP4 receptors contributes to prostaglandin E2-mediated stimulation of renal sensory nerves.
    Kopp UC; Cicha MZ; Nakamura K; Nüsing RM; Smith LA; Hökfelt T
    Am J Physiol Renal Physiol; 2004 Dec; 287(6):F1269-82. PubMed ID: 15292051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation.
    Kay LJ; Yeo WW; Peachell PT
    Br J Pharmacol; 2006 Apr; 147(7):707-13. PubMed ID: 16432506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin E2 differentially modulates human platelet function through the prostanoid EP2 and EP3 receptors.
    Petrucci G; De Cristofaro R; Rutella S; Ranelletti FO; Pocaterra D; Lancellotti S; Habib A; Patrono C; Rocca B
    J Pharmacol Exp Ther; 2011 Feb; 336(2):391-402. PubMed ID: 21059804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin E2 EP2 and EP4 receptor activation mediates cAMP-dependent hyperpolarization and exocytosis of renin in juxtaglomerular cells.
    Friis UG; Stubbe J; Uhrenholt TR; Svenningsen P; Nüsing RM; Skøtt O; Jensen BL
    Am J Physiol Renal Physiol; 2005 Nov; 289(5):F989-97. PubMed ID: 15985651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E-prostanoid (EP)2/EP4 receptor-dependent maturation of human monocyte-derived dendritic cells and induction of helper T2 polarization.
    Kubo S; Takahashi HK; Takei M; Iwagaki H; Yoshino T; Tanaka N; Mori S; Nishibori M
    J Pharmacol Exp Ther; 2004 Jun; 309(3):1213-20. PubMed ID: 14872092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of airway smooth muscle cell migration by E-prostanoid receptor subtypes.
    Aso H; Ito S; Mori A; Suganuma N; Morioka M; Takahara N; Kondo M; Hasegawa Y
    Am J Respir Cell Mol Biol; 2013 Mar; 48(3):322-9. PubMed ID: 23221043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.